Canlyniadau Chwilio - Gordon Cook

Mireinio'r Canlyniadau
  1. 1
    Enterobius vermicularis infection.

    Enterobius vermicularis infection. gan Gordon Cook

    Cyhoeddwyd 1994
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Lactase activity in newborn and infant Baganda.

    Lactase activity in newborn and infant Baganda. gan Gordon Cook

    Cyhoeddwyd 1967
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    High intestinal lactase concentrations in adult Arbs in Saudi Arabia.

    High intestinal lactase concentrations in adult Arbs in Saudi Arabia. gan Gordon Cook, Mohammed Altorki

    Cyhoeddwyd 1975
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network

    Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network gan Gordon Cook, Alessandra Larocca, Thierry Façon, Sonja Zweegman, Monika Engelhardt

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Guidelines for the investigation and management of mantle cell lymphoma

    Guidelines for the investigation and management of mantle cell lymphoma gan Pam McKay, Mike Leach, Robert M. Jackson, Gordon Cook, Simon Rule

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a <scp>UK</scp> population‐based study

    Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a <scp>UK</scp> population‐based study gan Debra Howell, Alexandra Smith, Simon Appleton, Timothy Bagguley, Una Macleod, Gordon Cook, Russell Patmore, Eve Roman

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma

    A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma gan M von Lilienfeld-Toal, Corinna Hahn‐Ast, Kerstin Furkert, Florian Hoffmann, Ralph Naumann, Ralf C. Bargou, Gordon Cook, Axel Glasmacher

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    The fate of human Langerhans cells in hematopoietic stem cell transplantation

    The fate of human Langerhans cells in hematopoietic stem cell transplantation gan Matthew Collin, Derek N.J. Hart, Graham Jackson, Gordon Cook, James Cavet, Stephen Mackinnon, Peter G. Middleton, Anne M. Dickinson

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent

    Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent gan Sylvia Feyler, Gina B. Scott, Christopher Parrish, Sarah Jarmin, Paul Evans, Mike Short, Katherine McKinley, Peter J. Selby, Gordon Cook

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells are increased whilst CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup>αβTCR<sup>+</sup> Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden

    CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells are increased whilst CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup>αβTCR<sup>+</sup> Double Negative T cells are... gan Sylvia Feyler, M von Lilienfeld-Toal, Sarah Jarmin, Lee Marles, Andy C. Rawstron, A. John Ashcroft, Roger G. Owen, Peter J. Selby, Gordon Cook

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

    Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation gan David I. Marks, Antonio Pagliuca, Christopher C. Kibbler, Axel Glasmacher, Claus Peter Heußel, Michal Kantecki, Paul Miller, Patricia Ribaud, Haran T. Schlamm, Carlos Solano, Gordon Cook

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

    Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma gan Kirsty Thomson, Emma Morris, Adrian Bloor, Gordon Cook, Don Milligan, Anne Parker, Fiona Clark, Lynny Yung, David C. Linch, Ronjon Chakraverty, Karl S. Peggs, Stephen Mackinnon

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Utility of a Commercially Available Multiplex Real-Time PCR Assay To Detect Bacterial and Fungal Pathogens in Febrile Neutropenia

    Utility of a Commercially Available Multiplex Real-Time PCR Assay To Detect Bacterial and Fungal Pathogens in Febrile Neutropenia gan Marie von Lilienfeld‐Toal, Lutz Lehmann, Ansgar Raadts, Corinna Hahn‐Ast, Katjana Orlopp, G. Marklein, Ingvill Purr, Gordon Cook, Andreas Hoeft, Axel Glasmacher, Frank Stüber

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial

    Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial gan Rakesh Popat, Sarah Brown, Louise Flanagan, Andrew Hall, Walter M. Gregory, Bhuvan Kishore, Matthew Streetly, Heather Oakervee, Kwee Yong, Gordon Cook, Eric Low, Jamie Cavenagh

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation

    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Bl... gan Gordon Cook, Graeme Smith, Keiren Kirkland, Jungwha Lee, Rachel Pearce, Kirsty Thomson, Emma Morris, Kim Orchard, Simon Rule, Nigel H. Russell, Charles Craddock, David I. Marks

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    IgM myeloma: a rare entity characterized by a CD20<sup>−</sup>CD56<sup>−</sup>CD117<sup>−</sup> immunophenotype and the t(11;14)

    IgM myeloma: a rare entity characterized by a CD20<sup>−</sup>CD56<sup>−</sup>CD117<sup>−</sup> immunophenotype and the t(11;14) gan Sylvia Feyler, Sheila J.M. O’Connor, Andy C. Rawstron, Chezhian Subash, Fiona M. Ross, Guy Pratt, Mark T. Drayson, John Ashcroft, Gordon Cook, Roger G. Owen

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond

    Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond gan Chor Sang Chim, Shaji Kumar, Robert Z. Orlowski, Gordon Cook, Paul G. Richardson, Morie A. Gertz, Sergio Giralt, M.V. Mateos, Xavier Leleu, Kenneth C. Anderson

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study

    Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study gan Julio Delgado, Kirsty Thomson, Nigel H. Russell, Joanne Ewing, Wendy A. Stewart, Gordon Cook, Stephen Devereux, Richard Lovell, Rajesh Chopra, David I. Marks, Stephen Mackinnon, Donald Milligan

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry

    Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantatio... gan Gordon Cook, Effie Liakopoulou, Rachel Pearce, Jim Cavet, Gareth J. Morgan, Keiren Kirkland, Julia Lee, Faith E. Davies, R. Hall, Amin Rahemtulla, Nigel H. Russell, David I. Marks

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma

    T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patient... gan Kirsty Thomson, Emma Morris, Don Milligan, Anne Parker, Ann E. Hunter, Gordon Cook, Adrian Bloor, Fiona Clark, Majid Kazmi, David C. Linch, Ronjon Chakraverty, Karl S. Peggs, Stephen Mackinnon

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: